When stock market volatility drives me nuts, I find relief in dividend stocks. Or rather, I rest in the top dividend stocks that I know will give me the right value no matter what the market does. And some of them have nothing to do with sitting in top-class dividend-paying stocks when they are still yielding high yields and lag behind the broader market, despite the visible growth catalysts ahead. Here are three stocks that caught my attention late.
Not all retail dumps are down
Realty income (NYSE: s) The stock is down about 12% to date. With a dividend yield of 3.3%, I think this is an attractive entry point.
After the coronavirus disease (COVID-19) lockdown, retail businesses shut down, hitting the realty business. Most of its tenants, after all, run retail stores.
Yet the nature of these tenants, their huge numbers and the business style of the realty income have saved the company from nasty shocks. Where is the evidence? In August Gust, realty revenue was 93.5..5% higher than the rent in June.87..8%.
You see, most of the tenants of realty income are inexperienced businesses that suffer from resilient demand. Think dollar stores, convenience stores and drug stores. Its five largest tenants are today Vg Grains, 7-eleven, Dr. General, FedEx, And Dwarf tree. Realty Revenue has a total of 600 tenants, making it a high quality custom portfolio.
A more important reason for being able to weather a realty income hurricane is that it is a real estate investment trust, i.e. it buys commercial properties and leases them. This is a long term lease, usually lasting 10 to 20 years. It’s also all triple-net leases, which means that tenants cover costs like maintenance and insurance while realty income only leases rent. They also have a built-in annual rental escalator. Historically, real-income same-store rental revenue has grown by 1% per year to 1.5%.
Image Source: Getty Images.
It is a reliable business model for generating stable income and realty income also promotes growth through acquisition of new assets. For 2020, management is targeting an acquisition of 1. 1.25 billion to અ 1.75 billion.
Here’s what I like most: The forecast monthly lease payments that collect realty income can easily support monthly dividends. Yes, realty income pays you a monthly check and its dividend has increased every year since it was declared in 1984. With the economy reopening, I like where realty income is placed today.
10% yielding energy stock? Yes, please
With the oil market booming in oil and gas stocks this year, it’s a surprise. Enterprise production partners (NYSE: EPD) As of this writing, the stock is down about 39% to date, bringing its dividend yield to a whopping 10.2%.
I may be keeping my distance from sky-high oil stocks today, but the Enterprise Product Partners dividend seems safe, especially after the medium energy company’s decision to cancel its M2E4 pipeline project, which does not guarantee additional pipeline capacity.
With the project now canceled, the enterprise expects its estimated growth capital costs to be reduced by 800 800 million by 2022. The company will use that money in the form of repurchase of the shares instead of replacing the debt and prize shareholders. The timing couldn’t be better. While management did not mention dividends, shareholders are likely to see an increase in dividends this year, to maintain an annual dividend groc track record of more than 20 years, even if only slightly.
Potential Dividend Growth, 10% -plus Yield, Strong Financial and a largely fee-based business that largely removes the company from the volatility of oil prices, all of these have really drawn my attention to this energy-free dividend stock.
I see an underpressured coronavirus stock here
Are you considering buying a healthcare stock that is already pushing its Covid-19 vaccine candidate into the tri-testing phase, but is still barely green this year? Let me also tell you that this is not a run-mill f-mill company, but one of the top brands of consumer health, pharmaceuticals and medical devices with a rich history of 130 years and under its belt. Oh, and this stock is also Dividend King, which has increased its dividend every year for more than 50 consecutive years?
Sounds tempting, right? That is Of Johnson and Johnson (NYSE: JNJ) For you – a dividend stock I will pile up for years to come.
In the current circumstances, at the speed at which Johnson and Johnson are in the race to produce the coronavirus vaccine, many people will have enough reason to buy stock. Phase 3 trials are set to begin by the end of September. But there are many other compelling catalysts that make it hard for the company to ignore.
A huge custom portfolio with 26 products or brands, bringing in at least 1 1 billion in annual sales, a formidable biotech pipeline, and a guilty track record of free cash flow and dividend growth over the decades, all make Johnson and Johnson top for revenue. Investors. And don’t forget the aggression with which the company grows: it’s about to be achieved Momenta Pharmaceuticals (Nasdaq: MNTA) Im 6.5 billion to advance in immunology.
With a yield of 2.7% for the 58-year-old dividend rising and booting, I think if Johnson & Johnson’s stock buys today it will go to places.
